Literature DB >> 7685197

Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor.

J E Damen1, A L Mui, L Puil, T Pawson, G Krystal.   

Abstract

The erythropoietin receptor (EpR) belongs to a family of hematopoietin receptors whose members lack tyrosine kinase activity. Nonetheless, within minutes of binding Ep, a number of cellular proteins become transiently phosphorylated on tyrosine residues. One of these proteins, as we and others have shown previously, is the EpR itself. To identify the remaining protein substrates, we have examined the antiphosphotyrosine immunoprecipitates of lysates from Ba/F3 cells expressing high levels of cell surface EpRs. We now present data showing that, in response to Ep, the 85-Kd regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase) becomes immunoprecipitable with antiphosphotyrosine antibodies. This appears to be due, in large part, to the specific association of PI 3-kinase with the tyrosine-phosphorylated EpR, either directly or through a 93- or 70-Kd tyrosine-phosphorylated intermediate. The activity of this EpR associated PI 3-kinase, assessed in anti-EpR immunoprecipitates, is maximal within 2 minutes of incubation with Ep and returns almost to baseline levels by 10 minutes. In vitro studies suggest that the interaction between PI 3-kinase and the activated EpR is mediated by the N- and C-terminal SH2 domains of p85 and tyrosine-phosphorylated motifs on the EpR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685197

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins.

Authors:  K Nishigaki; C Hanson; T Ohashi; D Thompson; K Muszynski; S Ruscetti
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.

Authors:  Ke Liang; Francisco J Esteva; Constance Albarracin; Katherine Stemke-Hale; Yang Lu; Giampaolo Bianchini; Ching-Yi Yang; Yong Li; Xinqun Li; Chun-Te Chen; Gordon B Mills; Gabriel N Hortobagyi; John Mendelsohn; Mien-Chie Hung; Zhen Fan
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

3.  Identification of K-ras as the major regulator for cytokine-dependent Akt activation in erythroid progenitors in vivo.

Authors:  Jing Zhang; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

4.  Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling.

Authors:  Erica A Dale; Irawan Satriotomo; Gordon S Mitchell
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

5.  The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.

Authors:  J E Damen; L Liu; P Rosten; R K Humphries; A B Jefferson; P W Majerus; G Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

6.  Erythropoietin receptors that signal through Stat5 or Stat3 support fetal liver and adult erythropoiesis: lack of specificity of stat signals during red blood cell development.

Authors:  S S Watowich; A Mikami; R A Busche; X Xie; P N Pharr; G D Longmore
Journal:  J Interferon Cytokine Res       Date:  2000-12       Impact factor: 2.607

7.  AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation.

Authors:  Saghi Ghaffari; Claire Kitidis; Wei Zhao; Dragan Marinkovic; Mark D Fleming; Biao Luo; Joseph Marszalek; Harvey F Lodish
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

8.  Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.

Authors:  Y Yamamura; H Senda; Y Kageyama; T Matsuzaki; M Noda; Y Ikawa
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

9.  Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase.

Authors:  Y Kubota; T Tanaka; A Kitanaka; H Ohnishi; Y Okutani; M Waki; T Ishida; H Kamano
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

10.  Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5.

Authors:  U Klingmüller; S Bergelson; J G Hsiao; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.